{"count":5,"index":{"built_at":"2026-07-28T03:55:14.074656+00:00","public_records":55311,"revision":"87a26518b7a5d480d14c11e6"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: COMT in the context of Wechseljahre"},"results":[{"answer":"COMT (catechol-O-methyltransferase) is an enzyme involved in the degradation of estrogens, particularly catechol estrogens. During menopause, estrogen production declines, and the remaining estrogens are increasingly metabolized via the COMT pathway. The common variant rs4680 (Val158Met) reduces enzyme activity (Met carriers). Observational studies suggest that Met carriers may have a higher risk of hot flashes, mood changes, and altered estrogen exposure. However, the evidence is mostly observational and not strong enough for clinical recommendations. GWAS associations are weak and not consistently replicated. A consumer DNA test for COMT cannot reliably predict menopausal symptom severity. Individual symptoms are influenced by hormone levels, lifestyle, stress, and diet. Interpreting such results without medical guidance is misleading. In summary: COMT has a plausible biological role, but the evidence for direct clinical utility in menopause is moderate and insufficient for personalized advice.","area":"gesundheit","canonical_id":"gesundheit:canonical-3353322e4e8cd6a7d0067bf9","id":"public-1456029338e0d730a518e489","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: COMT in the context of Wechseljahre","score":22.92965998,"snippet":"COMT (catechol-O-methyltransferase) is an enzyme involved in the degradation of estrogens, particularly catechol estrogens. During menopause, estrogen production declines, and the remaining estrogens are increasingly metabolized via the COMT pathway. The common variant rs4680 (Val158Met) reduces enzyme activity (Met carriers). Observational studies suggest that Met carriers may have a higher risk of hot flashes, mood changes, and altered estrogen exposure. However, the evidence is mostly observational and not strong enough for clinical recommendations. GWAS associations are weak and not consistently replicated. A consumer DNA test for COMT cannot reliably predict menopausal symptom severity.","sources":[],"title":"Evidence check: COMT in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-1456029338e0d730a518e489/evidence-check-comt-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Evidence for pharmacogenetic testing (e.g., Medicheck) in menopause is currently **moderate to mixed**. Genetic variants in enzymes like CYP2D6, CYP2C19, or COMT may influence the metabolism of hormone replacement therapy (HRT) or antidepressants. However, large prospective trials demonstrating clinical utility are lacking. Most evidence comes from pharmacokinetic data and observational studies, not RCTs. Routine use is not standard of care. Testing may be considered in individual cases (e.g., unexpected side effects or poor response) but should not replace clinical judgment. Be cautious of marketing claims.","area":"gesundheit","canonical_id":"gesundheit:canonical-e5ad3efe3cc95e0e80df30e3","id":"public-8b7f929c4f5235ca6925b40c","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Pharmakogenetik Medicheck in the context of Wechseljahre","score":21.63704921,"snippet":"Evidence for pharmacogenetic testing (e.g., Medicheck) in menopause is currently **moderate to mixed**. Genetic variants in enzymes like CYP2D6, CYP2C19, or COMT may influence the metabolism of hormone replacement therapy (HRT) or antidepressants. However, large prospective trials demonstrating clinical utility are lacking. Most evidence comes from pharmacokinetic data and observational studies, not RCTs. Routine use is not standard of care. Testing may be considered in individual cases (e.g., unexpected side effects or poor response) but should not replace clinical judgment. Be cautious of marketing claims.","sources":[],"title":"Evidence check: Pharmakogenetik Medicheck in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-8b7f929c4f5235ca6925b40c/evidence-check-pharmakogenetik-medicheck-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The question about the Omega-3 Index in the context of menopause is relevant, as omega-3 fatty acids have anti-inflammatory properties and are linked to cardiovascular and cognitive health. However, the provided knowledge context contains no specific data on the Omega-3 Index or menopause. The entries cover other SNPs (ESR1, COMT, PPARG, SOD2, rs10830963) and are insufficient for a direct answer. Therefore, the evidence from this context is rated as unclear. Generally, the Omega-3 Index (EPA+DHA in erythrocytes) is discussed as a risk marker for cardiovascular disease, and during menopause declining estrogen levels affect lipid metabolism. MyBody-X tests typically do not measure fatty acids directly but analyze DNA variants; a blood test for the Omega-3 Index would be more informative. For menopause-related health concerns, medical consultation is recommended.","area":"gesundheit","canonical_id":"gesundheit:canonical-4c3203b4048020a836b462df","id":"public-b94b3a573a79373fdfe7fb17","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Omega-3 Index in the context of Wechseljahre","score":21.16236484,"snippet":"The question about the Omega-3 Index in the context of menopause is relevant, as omega-3 fatty acids have anti-inflammatory properties and are linked to cardiovascular and cognitive health. However, the provided knowledge context contains no specific data on the Omega-3 Index or menopause. The entries cover other SNPs (ESR1, COMT, PPARG, SOD2, rs10830963) and are insufficient for a direct answer. Therefore, the evidence from this context is rated as unclear. Generally, the Omega-3 Index (EPA+DHA in erythrocytes) is discussed as a risk marker for cardiovascular disease, and during menopause declining estrogen levels affect lipid metabolism. MyBody-X tests typically do not measure fatty acids ","sources":[],"title":"Evidence check: Omega-3 Index in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-b94b3a573a79373fdfe7fb17/evidence-check-omega-3-index-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The 'INFINITY DNA-Test' by MyBody-X is marketed as a comprehensive test including a 28-day plan and recipe book, but the provided context lacks specific scientific evidence for its effectiveness in menopause. Menopause is a complex hormonal transition driven by declining estrogen levels. While DNA tests can identify variants in genes like CYP1A1, CYP1B1, or COMT that influence estrogen metabolism, the clinical relevance is often modest. Most menopausal symptoms (hot flashes, sleep disturbances, weight gain) are dominated by environment, lifestyle, and hormonal status, not single DNA markers. The included 28-day plan and recipe book may promote general healthy eating, but no randomized controlled trials validate this specific test for menopause. The evidence is best rated as 'marketing' or 'mixed'. Consumers should understand that such tests do not replace medical diagnosis, and professional guidance is essential for managing menopausal health.","area":"gesundheit","canonical_id":"gesundheit:canonical-6d8ce98b70f9a5728ac37251","id":"public-0d0661385f59e75ff17e9b61","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: INFINITY DNA-Test | inkl. 28-Tage-Plan & Rezeptbuch in the context of Wechseljahre","score":21.04316027,"snippet":"The 'INFINITY DNA-Test' by MyBody-X is marketed as a comprehensive test including a 28-day plan and recipe book, but the provided context lacks specific scientific evidence for its effectiveness in menopause. Menopause is a complex hormonal transition driven by declining estrogen levels. While DNA tests can identify variants in genes like CYP1A1, CYP1B1, or COMT that influence estrogen metabolism, the clinical relevance is often modest. Most menopausal symptoms (hot flashes, sleep disturbances, weight gain) are dominated by environment, lifestyle, and hormonal status, not single DNA markers. The included 28-day plan and recipe book may promote general healthy eating, but no randomized contro","sources":[],"title":"Evidence check: INFINITY DNA-Test | inkl. 28-Tage-Plan & Rezeptbuch in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-0d0661385f59e75ff17e9b61/evidence-check-infinity-dna-test-inkl-28-tage-plan-rezeptbuch-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Based on the provided context, there is no direct evidence addressing whether vitamin B12 is useful for menopause (Wechseljahre). The context covers DNA tests, carbohydrate metabolism, microbiome diversity, and COMT variants, but not B12 or menopause specifically. Generally, B12 is crucial for red blood cell formation, nerve function, and energy metabolism. A deficiency can cause fatigue, cognitive issues, and neurological symptoms that may overlap with menopausal complaints. However, robust clinical evidence from this context does not support B12 supplementation as a specific treatment for menopausal symptoms like hot flashes or mood swings. The evidence level is best described as unclear or marketing-driven. It is advisable to check B12 blood levels before supplementing, as excess can be harmful in certain conditions (e.g., kidney disease). In cases of confirmed deficiency, B12 is clearly indicated. Without deficiency, additional B12 likely offers no specific benefit for menopause. The answer should remain conservative: B12 is not a menopause cure-all but is important when deficient.","area":"gesundheit","canonical_id":"gesundheit:canonical-04b7d687908a6240ac89a17c","id":"public-d30290e897c38d86a8ad58bb","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Is B12 useful for Wechseljahre?","score":19.9889651,"snippet":"Based on the provided context, there is no direct evidence addressing whether vitamin B12 is useful for menopause (Wechseljahre). The context covers DNA tests, carbohydrate metabolism, microbiome diversity, and COMT variants, but not B12 or menopause specifically. Generally, B12 is crucial for red blood cell formation, nerve function, and energy metabolism. A deficiency can cause fatigue, cognitive issues, and neurological symptoms that may overlap with menopausal complaints. However, robust clinical evidence from this context does not support B12 supplementation as a specific treatment for menopausal symptoms like hot flashes or mood swings. The evidence level is best described as unclear o","sources":[],"title":"Is B12 useful for Wechseljahre?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-d30290e897c38d86a8ad58bb/is-b12-useful-for-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}